12-Month Lobbying Summary - In-house Corporation

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Subject matters were not required to be associated with subject matter details when this content was submitted	Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Discussion on the opioids crisis and the Health minister's expectations from pharmaceutical manufacturers	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Policies aimed at facilitating generic drugs repurposing.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Policies aimed at reinforcing pharmaceutical supply chain.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.	Grant, Contribution or Other Financial Benefit

  Subject matters in previous versions

  • Economic Development
  • Government Procurement
  • Health
  • Industry
  • Intellectual Property
  • International Trade
  • Municipalities
  • Regional Development
  • Research and Development
  • Science and Technology
  • Taxation and Finance

Government Institutions

• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Innovation, Science and Economic Development Canada (ISED)
• Prime Minister's Office (PMO)
• Transport Canada (TC)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Oral communication
• Grass-roots communication
• Written communication

Senior Officers whose lobbying activities represent less than 20% of their Duties

• David Goodman, Executive Chairman | No public offices held
• Morris Goodman, Co-Founder | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

• Ken Gagnon, Senior Manager, Government Affairs | No public offices held
• Julie Seïde, Director, Government Affairs | No public offices held

• Lobbyists in previous versions

  Senior Officers whose lobbying activities represent less than 20% of their Duties

  • Martin Arès, Chief Executive Officer | No public offices held

  Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

  • Sarah E Douglas, Head, Government & Public Affairs | Public offices held